Chronic Disease Management
The chronic disease management market encompasses consumers with chronic, complex conditions such as chronic kidney disease, diabetes, and heart disease. The challenges faced in this market are often compounded by the need for social services and supports. For provider organizations and health systems managing consumers with chronic conditions, a significant challenge that remains is addressing the rising cost of care for this population. As a result, payers are focusing on reducing the spend by increasing integrated models of care coordination across medical, behavioural, pharmacy, and social support systems. These new market forces are creating strategic opportunities for provider organizations that are serving this population.
Editor’s Picks
- CBT For Chronic Insomnia Most Effective With Cognitive Restructuring, Mindfulness, Sleep Restriction, Stimulus Control & In-Person Delivery
- Chronic Pain Affects Approximately 60% Of People Living With TBI Even Up To 30 Years After Injury
- Childhood Trauma Increases Risk Of Chronic Pain In Adulthood By 45%
- Chronic Health Problems More Prevalent Among Medicaid Beneficiaries Under Age 65 Who Use LTSS
Latest Resources
- CarelonRx Set To Launch Digital-First Weight Management Program
- Heart Disease Risk 50% Higher For People With Schizophrenia
- Evernorth Announces Financial Guarantee For GLP-1 Spend
- Data For Practice & Performance Improvement: The Cherokee Health Systems Team-Based Approach
- FDA Approves GLP-1 Wegovy To Reduce Risk Of Serious Heart Problems In Adults With Obesity Or Overweight
- WindRose Health Investors Acquires CardioOne
- Humana & Strive Health Expand Kidney Care Partnership To Three New States
- The ESOP Advantage
- Intellectual Disabilities Linked With Worse Cancer Survival
- CFO As Growth & Sustainability Engineer
- From Market & Financial Feasibility To Reality: Best Practice Service Line Research & Development
- Ten Options For Funding Innovation & Infrastructure
- Nimble In Knowledge & Talent: The Re-Skilling Imperative
- The First Law Of Service Line Development: Speed Matters
- North Carolina’s State Employee Health Plan Ends Coverage Of GLP-1 Drugs For Weight Loss Due To Cost Concerns
The North Carolina State Health Plan that covers 750,000 state employees and teachers ended coverage of glucagon-like peptide-1 (GLP-1) drugs for the purpose of weight loss (brand names Saxenda, Wegovy, and Zepbound), effective April 1, 2024. The coverage change does not affect members using the medications as treatment to manage Type 2 diabetes. GLP-1 agonists are drugs that mimic the effects of the natural GLP-1 hormone, which regulates blood sugar and appetite. Initially, the plan’s Board of Trustees had enacted… Read
- Arise Eating Disorder Platform Raises Nearly $6.5 Million
- The Changing Health Plan Perspective
- Presentation: ‘GLP-1 Medications For Weight Loss’ At The North Carolina State Health Plan Board Of Trustees Meeting, January 25, 2024
- Median Global Prevalence Of Chronic Kidney Disease Is 10%
- The Chronic Condition Conundrum
Government Contract Bidding Opportunities
- California Seeks Peer-Based Mentee For Contingency Management Access & Equity Programs
- South Carolina Seeks Job Task Analysis For SCDPS
- South Carolina’s Greenville County Seeks Health Screening & Fitness Testing For Sheriff’s Office & Emergency Medical Services
- Utah Seeks Medicaid Maximum Allowable Cost Pharmacy Pricing Services
Government Contract Award Announcements
- Nevada Awards Virtual Early Childhood Family Engagement Pilot Program Services Contract To Waterford Institute
- Colorado’s Delta County Awards Jail-Based Behavioral Health Services Contract To Behavioral Health & Wellness, PLLC
- Nevada Awards Federal Health Facility Inspection Services Contract To Healthcare Management Solutions, LLC
- North Dakota Awards Suicide & Crisis Lifeline 988 Evaluator Services Contract To TriWest Group, LLC
- Oregon’s City Of Beaverton Awards Drug Screen Testing Services Contract To Solutions Group NW, LLC